中国医药导报
中国医药期刊欢迎您 今天是   2025年4月28日星期一
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报
  护理研究 本期目录 | 过刊浏览 | 高级检索 |
改良急救护理路径结合规范化护理在急性脑梗死早期rt-PA静脉溶栓治疗中的应用
段贝贝
安徽省亳州市人民医院急诊内科,安徽亳州   236000
Application of improved emergency nursing pathway combined with standardized nursing in intravenous thrombolytic therapy of rt-PA in the early stage of acute cerebral infarction
DUAN Beibei
Department of Emergency Internal Medicine, Bozhou People’s Hospital, Anhui Province, Bozhou   236000, China
全文: PDF (554 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨改良急救护理路径结合规范化护理在急性脑梗死早期重组组织型纤溶酶原激活剂(rt-PA)静脉溶栓治疗中的应用效果。 方法 选择2020年5月至2021年10月安徽省亳州市人民医院急诊内科早期接受rt-PA静脉溶栓治疗的80例急性脑梗死患者作为研究对象。根据随机数字表法将其分为观察组和对照组,各40例。观察组给予改良急救护理路径结合规范化护理,对照组给予常规急救护理。比较两组溶栓治疗效果、急救时间、美国国立卫生研究院卒中量表(NIHSS)评分、日常生活能力(ADL)评分、并发症总发生率及患者满意度。结果 观察组治疗效果优于对照组(P<0.05)。观察组抽血送检时间、CT检查时间及入院至溶栓开始时间均短于对照组(P<0.05)。出院时,两组NIHSS评分低于入院时、ADL评分高于入院时,且观察组NIHSS评分低于对照组,ADL评分高于对照组,差异有统计学意义(P<0.05)。观察组溶栓治疗期间的并发症总发生率低于对照组(P<0.05)。观察组患者满意度优于对照组(P<0.05)。 结论 急性脑梗死患者应用改良急救护理路径结合规范化护理干预有助于提高早期rt-PA静脉溶栓治疗效果和急救效率,促进康复,减少并发症,且患者满意度高。

服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
段贝贝
关键词 急性脑梗死重组组织型纤溶酶原激活剂溶栓治疗改良急救护理路径规范化护理    
Abstract:Objective To explore the application effect of improved emergency nursing pathway combined with standardized nursing in intravenous thrombolytic therapy of recombinant tissue-type plasminogen activator (rt-PA) in the early stage of acute cerebral infarction. Methods Eighty patients with acute cerebral infarction who received early intravenous thrombolysis therapy with rt-PA in the Department of Emergency Internal Medicine of Bozhou People’s Hospital in Anhui Province from May 2020 to October 2021 were selected as the research objects. According to random number table methods, the patients were divided into observation group and control group, with 40 cases in each group. The observation group was given improved emergency nursing path combined with standardized nursing, and the control group was given routine emergency nursing. The efficacy of thrombolytic therapy, emergency time, National Institutes of Health stroke scale (NIHSS) score, activity of daily living (ADL) score, complication rate, and patient satisfaction were compared between the two groups. Results The treatment effect of observation group was better than control group (P<0.05). The time of blood sampling, CT examination, and the time from admission to thrombolysis in the observation group were shorter than those in the control group (P<0.05). At discharge, NIHSS score of the two groups was lower than that at admission, ADL score of the two groups were higher than that at admission, and NIHSS score of the observation group was lower than that of the control group, and ADL score of the observation group was higher than that of the control group, and the differences were statistically significant (P<0.05). The total incidence of complications in the observation group was lower than that in the control group (P<0.05). The satisfaction of patients in observation group was better than that in control group (P<0.05). Conclusion The application of improved emergency nursing pathway combined with standardized nursing intervention in patients with acute cerebral infarction is helpful to improve the efficacy of early rt-PA intravenous thrombolysis and emergency efficiency, promote rehabilitation, reduce complications, and the patient satisfaction is high.
Key wordsAcute cerebral infarction    Recombinant tissue-type plasminogen activator    Thrombolytic therapy    Improved emergency nursing pathway    Standardized nursing
    
引用本文:   
段贝贝. 改良急救护理路径结合规范化护理在急性脑梗死早期rt-PA静脉溶栓治疗中的应用[J]. 中国医药导报, 2023, 20(15): 180-183.
DUAN Beibei. Application of improved emergency nursing pathway combined with standardized nursing in intravenous thrombolytic therapy of rt-PA in the early stage of acute cerebral infarction. 中国医药导报, 2023, 20(15): 180-183.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/10.20047/j.issn1673-7210.2023.15.40     或     https://www.yiyaodaobao.com.cn/CN/Y2023/V20/I15/180

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司